Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2025Mar 3 4:59 PMBecklund Irene
Proposed Sale
2,913$45.14$131.5K—

View →

Mar 3, 2025Mar 3 4:45 PMBoughton Soleil
Proposed Sale
4,151$45.14$187.4K—

View →

Feb 24, 2025Feb 24 3:46 PMChi Michael
Proposed Sale
17,303$48.14$833.0K—

View →

Feb 19, 2025Feb 19 3:16 PMChi Michael
Proposed Sale
7,500$59.26$444.4K—

View →

Feb 18, 2025Feb 18 4:22 PMBoughton Soleil
Proposed Sale
4,152$60.69$252.0K—

View →

Feb 18, 2025Feb 18 4:10 PMDudum Andrew
Proposed Sale
175,661$58.24$10.2M—

View →

Feb 12, 2025Feb 12 9:36 PMMelissa Baird
Proposed Sale
67,687$46.34$3.1M—

View →

Feb 10, 2025Feb 10 5:09 PMChi Michael
Proposed Sale
7,259$43.28$314.2K—

View →

Feb 3, 2025Feb 3 4:11 PMBoughton Soleil
Proposed Sale
4,153$35.30$146.6K—

View →

Feb 3, 2025Feb 3 4:11 PMChi Michael
Proposed Sale
2,054$35.30$72.5K—

View →

Jan 31, 2025Jan 31 3:43 PMDudum Andrew
Proposed Sale
100,000$35.22$3.5M—

View →

Jan 24, 2025Jan 24 2:53 PMChi Michael
Proposed Sale
17,304$31.00$536.4K—

View →

Jan 23, 2025Jan 23 5:55 PMDudum Andrew
Proposed Sale
27,098$30.08$815.0K—

View →

Jan 22, 2025Jan 22 9:24 PMDudum Andrew
Proposed Sale
14,269$30.08$429.2K—

View →

Jan 21, 2025Jan 21 9:55 PMMelissa Baird
Proposed Sale
67,687$29.81$2.0M—

View →

Jan 21, 2025Jan 21 9:54 PMDudum Andrew
Proposed Sale
300$30.00$9.0K—

View →

Jan 21, 2025Jan 21 9:32 PMBoughton Soleil
Proposed Sale
54,153$29.90$1.6M—

View →

Jan 21, 2025Jan 21 3:16 PMChi Michael
Proposed Sale
306$28.68$8.8K—

View →

Jan 16, 2025Jan 16 5:40 PMDudum Andrew
Proposed Sale
83,994$27.04$2.3M—

View →

Jan 10, 2025Jan 10 3:39 PMChi Michael
Proposed Sale
7,259$24.07$174.7K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4